1 unchanged sentence
Issuer Purchases of Equity Securities
−Removed: The following table provides information on the Company’s share repurchases during the third quarter of fiscal 2020:
−Removed: Number of Shares
−Removed: Average Price Paid per Share
−Removed: Total Number of Shares Purchased as Part of Publicly Announced Program
−Removed: Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (1)
−Removed: September 29, 2019 - October 26, 2019
−Removed: October 27, 2019 - November 23, 2019
−Removed: November 24, 2019 - December 28, 2019
−Removed: (1) In May 2019, the Company announced that the Board of Directors had authorized the repurchase of up to $500 million of the Company’s common stock from time to time, based on market conditions, over the next two years.
−Removed: Under the Company's share repurchase program, shares may be repurchased in accordance with applicable laws both on the open market, including under trading plans established pursuant to Rule 10b5-1 under the Exchange Act, and in privately negotiated transactions.
−Removed: (2) In October 2019, the Company completed a $50.0 million repurchase of its common stock pursuant to an accelerated share repurchase agreement ("ASR") entered into with Morgan Stanley & Co.
−Removed: LLC ("Morgan Stanley") in September 2019.
−Removed: The total number of shares repurchased under the ASR was 0.4 million at an average price per share upon final settlement of $124.37.
−Removed: (3) In December 2019, the Company entered into an ASR with Bank of America, N.A.
−Removed: ("Bank of America") to repurchase $50.0 million of the Company’s common stock.
−Removed: Pursuant to the terms of the ASR, in December 2019, the Company paid Bank of America $50.0 million in cash and received an initial delivery of 0.3 million shares of the Company's common stock based on a closing market price on the New York Stock Exchange on December 11, 2019 of $117.55.
−Removed: This initial delivery of shares represented approximately 80% of the notional amount of the ASR.
−Removed: On January 23, 2020, the ASR was completed and an additional 0.1 million shares were delivered upon settlement.
−Removed: The total number of shares repurchased under the ASR was 0.4 million at an average price per share upon final settlement of $114.73.
+Added: In May 2019, our Board of Directors authorized the repurchase of up to $500 million of Haemonetics common shares over the next two years.
+Added: We had no share repurchases during the three months ended June 27, 2020.
+Added: The total remaining authorization for repurchases of our common stock under the share repurchase program was $325 million as of June 27, 2020.
Defaults Upon Senior Securities
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.